Resultats de la cerca - Alejandra González‐Duarte
- Mostrar 1 - 20 resultats de 30
- Anar a la pàgina següent
-
1
Cocaine-Induced Recurrent Leukoencephalopathy per Alejandra González‐Duarte, Ricardo Williams
Publicat 2013Artigo -
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
Diagnosis and treatment of hereditary transthyretin amyloidosis with polyneuropathy in the <scp>United States</scp>: <scp>Recommendations</scp> from a panel of experts per Chafic Karam, Michelle L. Mauermann, Alejandra González‐Duarte, Michelle Kaku, Senda Ajroud‐Driss, Thomas H. Brannagan, Michael Polydefkis
Publicat 2024Artigo -
10
Development of measures of polyneuropathy impairment in hATTR amyloidosis: From NIS to mNIS + 7 per P. James B. Dyck, Alejandra González‐Duarte, Laura Obici, Michael Polydefkis, Janice F. Wiesman, Ilia Antonino, William J. Litchy, P. James B. Dyck
Publicat 2019Revisão -
11
Neurological manifestations temporally associated with SARS-CoV-2 infection in pediatric patients in Mexico per Areli Estela Sánchez-Morales, Marta Urrutia-Osorio, Esteban Camacho-Mendoza, Gustavo Rosales-Pedraza, Luis Dávila-Maldonado, Alejandra González‐Duarte, Patricia Herrera-Mora, Matilde Ruiz García
Publicat 2021Artigo -
12
Characteristics of patients with autonomic dysfunction in the Transthyretin Amyloidosis Outcomes Survey (THAOS) per Fábio Barroso, Teresa Coelho, Angela Dispenzieri, Isabel Conceição, Márcia Waddington‐Cruz, Jonas Wixner, Mathew S. Maurer, Claudio Rapezzi, Violaine Planté‐Bordeneuve, Arnt V. Kristen, Alejandra González‐Duarte, Doug Chapman, Michelle Stewart, Leslie Amass
Publicat 2022Artigo -
13
Efficacy and safety of vutrisiran for patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: a randomized clinical trial per David Adams, Ivailo Tournev, Mark Taylor, Teresa Coelho, Violaine Planté‐Bordeneuve, John L. Berk, Alejandra González‐Duarte, Julian D. Gillmore, Soon-Chai Low, Yoshiki Sekijima, Laura Obici, Chongshu Chen, Prajakta Badri, Seth Arum, Joshua R. Vest, Michael Polydefkis
Publicat 2022Artigo -
14
Analysis of autonomic outcomes in APOLLO, a phase III trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosis per Alejandra González‐Duarte, John L. Berk, Dianna Quan, Michelle L. Mauermann, Hartmut Schmidt, Michael Polydefkis, Márcia Waddington‐Cruz, Mitsuharu Ueda, Isabel Conceição, Arnt V. Kristen, Teresa Coelho, Cécile Cauquil, Céline Tard, Madeline Merkel, Emre Aldinc, Jihong Chen, Marianne T. Sweetser, Jing Jing Wang, David Adams
Publicat 2019Artigo -
15
Quality of life outcomes in APOLLO, the phase 3 trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosis per Laura Obici, John L. Berk, Alejandra González‐Duarte, Teresa Coelho, Julian D. Gillmore, Hartmut Schmidt, Matthias Schilling, Taro Yamashita, Céline Labeyrie, Thomas H. Brannagan, Senda Ajroud‐Driss, Peter D. Gorevic, Arnt V. Kristen, Jaclyn Franklin, Jihong Chen, Marianne T. Sweetser, Jing Jing Wang, David Adams
Publicat 2020Artigo -
16
Correction to: Analysis of autonomic outcomes in APOLLO, a phase III trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosis per Alejandra González‐Duarte, John L. Berk, Dianna Quan, Michelle L. Mauermann, Hartmut Schmidt, Michael Polydefkis, Márcia Waddington‐Cruz, Mitsuharu Ueda, Isabel Conceição, Arnt V. Kristen, Teresa Coelho, Cécile Cauquil, Céline Tard, Madeline Merkel, Emre Aldinc, Jihong Chen, Marianne T. Sweetser, Jing Jing Wang, David Adams
Publicat 2020Errata/Corrigenda -
17
Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated Amyloidosis per Scott D. Solomon, David Adams, Arnt V. Kristen, Martha Grogan, Alejandra González‐Duarte, Mathew S. Maurer, Giampaolo Merlini, Thibaud Damy, Michel Slama, Thomas H. Brannagan, Angela Dispenzieri, John L. Berk, Amil M. Shah, Pushkal Garg, Akshay Vaishnaw, Verena Karsten, Jihong Chen, Jared Gollob, Joshua R. Vest, Ole B. Suhr
Publicat 2019Artigo -
18
A 15-year consolidated overview of data in over 6000 patients from the Transthyretin Amyloidosis Outcomes Survey (THAOS) per Luca Gentile, Teresa Coelho, Angela Dispenzieri, Isabel Conceição, Márcia Waddington‐Cruz, Arnt V. Kristen, Jonas Wixner, Igor Diemberger, Juan González‐Moreno, Eve Cariou, Mathew S. Maurer, Violaine Planté‐Bordeneuve, Pablo García‐Pavía, Ivailo Tournev, José González‐Costello, Alejandra González‐Duarte, Martha Grogan, Anna Mazzeo, Doug Chapman, Pritam Gupta, Oliver Glass, Leslie Amass
Publicat 2023Artigo -
19
Neurologic manifestations in hospitalized patients with COVID-19 in Mexico City per Fernando Flores-Silva, Miguel García‐Grimshaw, Sergio Iván Valdés‐Ferrer, Alma Poema Vigueras-Hernández, Rogelio Domínguez-Moreno, Dioselina Panamá Tristán-Samaniego, Anaclara Michel‐Chávez, Alejandra González‐Duarte, Felipe Vega-Boada, Isael Reyes-Melo, Amado Jiménez‐Ruiz, Oswaldo Alan Chávez-Martínez, Daniel Rebolledo-García, Osvaldo Alexis Marché-Fernández, Samantha Sánchez-Torres, Guillermo García‐Ramos, Carlos Cantú‐Brito, Erwin Chiquete
Publicat 2021Artigo -
20
137 PRIMARY RESULTS FROM APOLLO-B, A PHASE 3 STUDY OF PATISIRAN IN PATIENTS WITH TRANSTHYRETIN-MEDIATED AMYLOIDOSIS WITH CARDIOMYOPATHY per Simone Longhi, Matthew J. Maurer, Marianna Fontana, John L. Berk, Finn Gustafsson, Marcos Simões, Martha Grogan, Fábio Fernandes, Robert Gottlieb, Miloš Kubánek, Steen Hvitfeldt Poulsen, Thibaud Damy, Igor Diemberger, Nobuhiro Tahara, Wen-chuhg Yu, W.H. Wilson Tang, Laura Obici, Alejandra González‐Duarte, Yoshiki Sekijima, Matthew T. White, Elena Yureneva, Patrick Y. Jay, Joshua R. Vest, Julian D. Gillmore
Publicat 2022Artigo
Eines de cerca:
Matèries relacionades
Medicine
Internal medicine
Amyloidosis
Transthyretin
Disease
Pathology
Polyneuropathy
Alternative medicine
Biology
Cardiac amyloidosis
Cardiology
Pediatrics
Placebo
Surgery
Cardiomyopathy
Gastroenterology
Genetics
Heart failure
Intensive care medicine
Asymptomatic
Blood pressure
Engineering
Gene
Mechanical engineering
Nursing
Quality of life (healthcare)
Stroke (engine)
Amyloid (mycology)
Clinical trial
Coronavirus disease 2019 (COVID-19)